Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats

<p>Abstract</p> <p>Background</p> <p>Although diabetes mellitus (DM) can be treated with islet transplantation, a scarcity of donors limits the utility of this technique. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord could be in...

Full description

Bibliographic Details
Main Authors: Tsai Pei-Jiun, Wang Hwai-Shi, Shyr Yi-Ming, Weng Zen-Chung, Tai Ling-Chen, Shyu Jia-Fwu, Chen Tien-Hua
Format: Article
Language:English
Published: BMC 2012-04-01
Series:Journal of Biomedical Science
Subjects:
Online Access:http://www.jbiomedsci.com/content/19/1/47
_version_ 1811278498168307712
author Tsai Pei-Jiun
Wang Hwai-Shi
Shyr Yi-Ming
Weng Zen-Chung
Tai Ling-Chen
Shyu Jia-Fwu
Chen Tien-Hua
author_facet Tsai Pei-Jiun
Wang Hwai-Shi
Shyr Yi-Ming
Weng Zen-Chung
Tai Ling-Chen
Shyu Jia-Fwu
Chen Tien-Hua
author_sort Tsai Pei-Jiun
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Although diabetes mellitus (DM) can be treated with islet transplantation, a scarcity of donors limits the utility of this technique. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord could be induced efficiently to differentiate into insulin-producing cells. Secondly, we evaluated the effect of portal vein transplantation of these differentiated cells in the treatment of streptozotocin-induced diabetes in rats.</p> <p>Methods</p> <p>MSCs from human umbilical cord were induced in three stages to differentiate into insulin-producing cells and evaluated by immunocytochemistry, reverse transcriptase, and real-time PCR, and ELISA. Differentiated cells were transplanted into the liver of diabetic rats using a Port-A catheter via the portal vein. Blood glucose levels were monitored weekly.</p> <p>Results</p> <p>Human nuclei and C-peptide were detected in the rat liver by immunohistochemistry. Pancreatic β-cell development-related genes were expressed in the differentiated cells. C-peptide release was increased after glucose challenge <it>in vitro</it>. Furthermore, after transplantation of differentiated cells into the diabetic rats, blood sugar level decreased. Insulin-producing cells containing human C-peptide and human nuclei were located in the liver.</p> <p>Conclusion</p> <p>Thus, a Port-A catheter can be used to transplant differentiated insulin-producing cells from human MSCs into the portal vein to alleviate hyperglycemia among diabetic rats.</p>
first_indexed 2024-04-13T00:37:00Z
format Article
id doaj.art-b4d2a10ca1964e899ba63c909d99a3ff
institution Directory Open Access Journal
issn 1021-7770
1423-0127
language English
last_indexed 2024-04-13T00:37:00Z
publishDate 2012-04-01
publisher BMC
record_format Article
series Journal of Biomedical Science
spelling doaj.art-b4d2a10ca1964e899ba63c909d99a3ff2022-12-22T03:10:19ZengBMCJournal of Biomedical Science1021-77701423-01272012-04-011914710.1186/1423-0127-19-47Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic ratsTsai Pei-JiunWang Hwai-ShiShyr Yi-MingWeng Zen-ChungTai Ling-ChenShyu Jia-FwuChen Tien-Hua<p>Abstract</p> <p>Background</p> <p>Although diabetes mellitus (DM) can be treated with islet transplantation, a scarcity of donors limits the utility of this technique. This study investigated whether human mesenchymal stem cells (MSCs) from umbilical cord could be induced efficiently to differentiate into insulin-producing cells. Secondly, we evaluated the effect of portal vein transplantation of these differentiated cells in the treatment of streptozotocin-induced diabetes in rats.</p> <p>Methods</p> <p>MSCs from human umbilical cord were induced in three stages to differentiate into insulin-producing cells and evaluated by immunocytochemistry, reverse transcriptase, and real-time PCR, and ELISA. Differentiated cells were transplanted into the liver of diabetic rats using a Port-A catheter via the portal vein. Blood glucose levels were monitored weekly.</p> <p>Results</p> <p>Human nuclei and C-peptide were detected in the rat liver by immunohistochemistry. Pancreatic β-cell development-related genes were expressed in the differentiated cells. C-peptide release was increased after glucose challenge <it>in vitro</it>. Furthermore, after transplantation of differentiated cells into the diabetic rats, blood sugar level decreased. Insulin-producing cells containing human C-peptide and human nuclei were located in the liver.</p> <p>Conclusion</p> <p>Thus, a Port-A catheter can be used to transplant differentiated insulin-producing cells from human MSCs into the portal vein to alleviate hyperglycemia among diabetic rats.</p>http://www.jbiomedsci.com/content/19/1/47Mesenchymal stem cellPortal veinInsulin-producing cellsTransplant
spellingShingle Tsai Pei-Jiun
Wang Hwai-Shi
Shyr Yi-Ming
Weng Zen-Chung
Tai Ling-Chen
Shyu Jia-Fwu
Chen Tien-Hua
Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
Journal of Biomedical Science
Mesenchymal stem cell
Portal vein
Insulin-producing cells
Transplant
title Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
title_full Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
title_fullStr Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
title_full_unstemmed Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
title_short Transplantation of insulin-producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin-induced diabetic rats
title_sort transplantation of insulin producing cells from umbilical cord mesenchymal stem cells for the treatment of streptozotocin induced diabetic rats
topic Mesenchymal stem cell
Portal vein
Insulin-producing cells
Transplant
url http://www.jbiomedsci.com/content/19/1/47
work_keys_str_mv AT tsaipeijiun transplantationofinsulinproducingcellsfromumbilicalcordmesenchymalstemcellsforthetreatmentofstreptozotocininduceddiabeticrats
AT wanghwaishi transplantationofinsulinproducingcellsfromumbilicalcordmesenchymalstemcellsforthetreatmentofstreptozotocininduceddiabeticrats
AT shyryiming transplantationofinsulinproducingcellsfromumbilicalcordmesenchymalstemcellsforthetreatmentofstreptozotocininduceddiabeticrats
AT wengzenchung transplantationofinsulinproducingcellsfromumbilicalcordmesenchymalstemcellsforthetreatmentofstreptozotocininduceddiabeticrats
AT tailingchen transplantationofinsulinproducingcellsfromumbilicalcordmesenchymalstemcellsforthetreatmentofstreptozotocininduceddiabeticrats
AT shyujiafwu transplantationofinsulinproducingcellsfromumbilicalcordmesenchymalstemcellsforthetreatmentofstreptozotocininduceddiabeticrats
AT chentienhua transplantationofinsulinproducingcellsfromumbilicalcordmesenchymalstemcellsforthetreatmentofstreptozotocininduceddiabeticrats